Interestingly, T has also beneficial immunological effects relevant for MS [61], and CXCL12/CXCR4 signaling is protective in EAE by preventing lymphocytes from invading the CNS and by restraining autoimmune inflammatory processes [62, 63]. Here, CXCL12 is linked to myeloid sarcoma.